LOGC

LogicBio Therapeutics, Inc. Common Stock

Delisted

LOGC was delisted on the 15th of November, 2022.

57 hedge funds and large institutions have $73.2M invested in LogicBio Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 11 closing their positions.

Holders
57
Holders Change
-6
Holders Change %
-9.52%
% of All Funds
1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
10
Reduced
19
Closed
11
Calls
$14K
Puts
$57K
Net Calls
-$43K
Net Calls Change
-$41K
Name Market Value Shares Shares
Change
Shares
Change %
O
1
OrbiMed
New York
$38.8M 8,466,783
Franklin Resources
2
Franklin Resources
California
$7.32M 1,598,644
SC
3
Samlyn Capital
New York
$6.75M 1,474,108 +53,656 +4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$3.35M 730,572 +14,790 +2%
LPC
5
Lion Point Capital
New York
$2.29M 500,000
BBA
6
Baker Bros. Advisors
New York
$2.07M 451,478
EP
7
Eversept Partners
New York
$1.6M 349,919 +349,919 New
PIM
8
Platinum Investment Management
Australia
$1.47M 320,273 +320,273 New
Fidelity Investments
9
Fidelity Investments
Massachusetts
$1.45M 315,500 -184,500 -37%
PVI
10
Pura Vida Investments
New York
$1.12M 245,492 -3,764 -2%
BlackRock
11
BlackRock
New York
$988K 215,736 -5,412 -2%
SCM
12
Sio Capital Management
New York
$836K 182,630
BCM
13
Bridgeway Capital Management
Texas
$808K 176,500 +100,000 +131%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$634K 138,465 +6,344 +5%
Verition Fund Management
15
Verition Fund Management
Connecticut
$520K 113,532 -94,567 -45%
E
16
Ergoteles
New York
$301K 65,827 -956 -1%
UBS Group
17
UBS Group
Switzerland
$286K 62,493 -2,601 -4%
Millennium Management
18
Millennium Management
New York
$222K 48,559 -45,755 -49%
Renaissance Technologies
19
Renaissance Technologies
New York
$216K 47,200 -49,300 -51%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$211K 46,175 +17,791 +63%
Goldman Sachs
21
Goldman Sachs
New York
$193K 42,186 -12,844 -23%
HF
22
HRT Financial
New York
$192K 42,074 -3,323 -7%
Marshall Wace
23
Marshall Wace
United Kingdom
$181K 39,523 -1,045 -3%
FT
24
Fiduciary Trust
Massachusetts
$174K 37,998
SMH
25
Sanders Morris Harris
Texas
$160K 35,000 +20,000 +133%